Table Of Content

Author index to volume 68, 1992 A Caraballo L 525 H Carreira J 398 Acosta O 483 Carrillo T 483 Hamburger RN 200 Adachi Y 261 Castillo R 483 Hamilos DL 307, 472 Adachi YS 261 Caveliere LF 324 Harada T 407 Ades EW 47 Chanez P 159 Harman E 169 Agata H 438 Church JA 215 Hashimoto K 184 Agopian MS 472 Ciprandi G 251 Hauser B 419 Akasawa A 184 Cockcroft DW 245, 360 Hendeles L 169 Akimoto K 184 Corbeil F 363 Henderson DK 197, 375 Altman KA 324 Couret I 159 Hernandez JR. 165 Altman LC 500 Crowley JP 27 Hinojosa M 515 Altman RA 348 Cuesta J 515 Horner § 493 Armentia A 398 Cuevas M 483, 515 Huang L 228 Asbrink E 255 Huber F 228 Ayars GH 500 Hunt LW 453 D B I Dal Bo S 433 Baba M 233 D’Amato G 433 Igarashi T 261 Barber D 398 Davila 1 515 Igea JM 515 Bardana E 371 de la Fuente R 398 Barka N 472 Dockhorn RJ 348 Iklé DN 472 Barrett D 274 Dogar JH 307 Iwasaki A 184 Becker H 354 Dolen WK 35 Bellanti JA 404 Dreborg S 334 Benedetti M 404 J Benn VJ 500 Jager R 354 Berman BA 348 Jing G 251 Bernstein L 488 Bielory L 467 F Jones RT 223 Johnson J 237 Bierman CW 119, 488 Findlay S 228 Juel K 180 Bigelsen S 467 Fitch KD 143 Biskin N 274, 331 Fraj J 575 Blake KV 169 Freund LH 395 Boe J 255 Fuente R 345 K Boero F 251 Fujimura M 53 Kanarek H 493 Bonagura VR 392 Fukutomi O 438 Kang BC 237 Boner AL 404 Kardassakis DG 279 Bonini S 433 Katsunuma T 184 Boulet L-P 363 Kayahara M 261 Bousquet J 159 Kemp JP 488 Brayer M 175 G Keshimiri M 245 Buchman E 348 Galosi A 334 Kimura Y 530 Burow G 334 Garcia J 228 King K 493 Buscaglia S 251 Gengo FM 359 Kivity S 175 Busse WW 286 Georgitis JW 413 Klaustermeyer WB 139 Gergen PJ 507 Koepke JW 35 Gimeno F 155 Koéter GH 155 Go EF 324 Kohl I 354 * Godard P 159 Kondo N 438 Cadavid A 525 Gonzalez Quintela A 345 Koziol DE 375 Caminero J 483 Gordon EH 395 Kramer RA 507 Campbell AM 159 Gore BC 245 Kurashima K 53 Canestrari DA 165 Gottschlich G 413 Kurohara ML 139 Canonica GW 251 Grekin RC 279 Kwong FK 139 VOLUME 68, JUNE, 1992 L Oppenheimer JJ 17 Spinks JA 425 Orii T 438 Squillace DL 223 LeBoit PE 279 Ownby DR 3 Stafford CT 47 Leese PT 348 Stiksa G 255 Leffell MS 47 Stone BD 413 Li CK 425 Strunk R 291 Li JT 488 P Sue MA 395 Lin RY 324 Patel PC 360 Sumazaki R 315 Ljungstedt-PahIman I 334 Pedersen PA 180 Svensson K 255 Lorenzana FG 324 Pesce G 251 Love SJ 348 Peter JB 472 Lutz C 23 Peterson EL 3 T Piacentini GL 404 Popick FR 500 Takeda K 315 Portnoy J 493 Takita H 315 M Pritchard D 27 Talaricoficho § 233 Maclaren N 5 Przybilla B 334 Tominaga Y 407 Mansmann HC 348 Tapias J 398 Margileth AM 149 Tashkin DP 267 Marks MB | Thompson WO 47 Martin J 398 R Tinkelman DG 23, 488 Matsuda T 53 Reed CE 267 Tonnesen MG 17 Matsunaga T 407 Richards W 215 Topilsky M 175 Matsuno M 261 Rieger CHL 354 Torrano RT 215 Mazza JA 267 Rihoux JP 251 Townley RG 190 McCurdy D 215 Riker DK 165 Tseng RYM 425 Mendoza J 525 Ring J 334 Turcotte H 363 Michaels J 467 Rodriguez JC 483 Turkeltaub PC 507 Michel FB 159 Rodriguez de Castro F 483 Middleton E 348 Rosenow EC III 453 Mikawa H 233 Ruffoni S 251 Miller RD 165 U a Miller SD 27 Umagae Y 319 Minotti DA 500 Morton AR 143 S Murakami G 261 Sacre L 419 V Murdock KY 245 Salcedo G 398 van Altena R 155 Sanchez P 398 Vandenborre C 419 Sato K 520 Vandenplas Y 419 Schafer T 334 N van der Weele LTh 155 Schatz M 123 Vidal C 345 Nakazawa T 319, 520 Schauer U 354 Naspitz CK 233 Schiff RI 447 Nelson HS 17, 307 Schuval SJ 392 Nishima § 233 Sedgwick JB 286 Ww Nogami T 315 Selner JC 35 Williams PB 35 Shibasaki M 315 Wise SL 47 Shinbara M 438 Witek TJ Jr 165 O Shinoda S 438 Wu CW 237 Siegel SC 488 Obata T 530 Silvers WS 58 O'Donnell R 340 Slater JE 203 Ogawa H 53 Sly RM 340 Y Ogino S 407 Small P 30, 274, 331 Yang JY 165 Ogle SL 143 Smith TF 293 Yarbrough JA 47 Ohka T 53 Sole D 233 Yoshizumi A 261 Okada C 190 Spangenberg RD 488 Young RM 472 Okada T 261 Spezia E 404 Yunginger JW 223 ANNALS OF ALLERGY Subject index to volume 68, 1992 A T cells 354 Dimaprit, effect of IgE production 319 Autoantibodies [Abstact] A-22 Drugs, beta adrenergic 453 Acquired immunodeficiency syndrome 197 prophylactic [Abstract] 188 Aggamaglobulemia 215 B E Albuterol [Abstract] 52, 169, [Abstract] 196, 267, [Abstract] 524 Babyhaler inhaler [Abstract] 196 Eosinophils in asthma 286 effect on bronchial hyperresponsiveness Behcet’s syndrome 17 Erythema multiforme 19 [Abstract] 481 Beta-adrenergic agonist 23 Exercise-induced bronchospasm, effect of al- effect on late phase reactions [Abstract] Beta-adrenergic drugs 453 lergen challenge 363 481 Beta-lactam antibiotics, crossreactivity to 515 nebulized in infants [Abstract] 506 Bronchiolitis obliterans 307 Allergen stimulation 159 Bronchitis, chronic, treatment [Abstract] 52, G Allergy 524 cockroach 237 Bronchospasm, late asthmatic responses 363 Gammaglobulin, intravenous [Abstract] A- cow milk 200, 223 Budesonide [Abstract] 34 22 [Abstract] 399, [Abstract] 353, 447 egg [Letter] 69 latex 203 lobster 360 H Alpha-1-antitrypsin deficiency 307 C Anaphylaxis 203, 233, 453 Hepatitis B 197 CAP system 35 Anaphylaxis, exercise-induced 58 Herpes simplex 17, 47 CD4, on antigen-activated T cells in asthma Angiotensin-converting enzyme inhibitor Human immunodeficiency virus 197 354 453 Human immunodeficiency virus infection CD8, on antigen 354 Antihistamine [Abstract] 318 Calcium channel blockers 175 loratadine 30 Hyperresponsiveness, bronchial 175, 481 Cat scratch disease 149 terfenadine 30 Hypersensitivity bronchial [Abstract] 492 Cetirizine 190, 348 Antihistamines 190 Hypogammaglobulinemia 165 Cetirizine, lack of effect on immune re- Antihistamines, effect on IgE production 319 in asthma 472 sponses 251 Arthritis 215 Chemotaxis 190 Aspirin, sensitivity to 453 Cimetidine, effect on IgE production 319 Asthma I Clemastine 245 age of onset 507 Cocaine, adverse reactions to 139 clinical score 530 Cockroach allergy 237 IgA deficiency 467 effect of pregnancy 123 IgE [Abstract] 492 Complement, in asthma 324 eosinophils in 286 age-related changes 520 exercise-induced 58, 119, 143, 363 Coratsiscoocsitaetriooind s,w itahd rehnyaplo gammaglobulinemia production in mice 319 hypogammaglobulinemia 472 472 Immunodeficiency 47, 447 mortality 180, 291, 340 Co-trimoxazole [Abstract] 188 Immunotherapy nnaoscatlu rcnlaela ra[Anbcset rianc t5]3 487 CCroowm omliylnk, a1l, l2er4g5y 200, 223 wriutshh 49m3o nomethoxy polyethylene glycol porcecmupeantsitornuaall 336105 Cromolyn sodium 143 In memmodoirfiiaedm grass pollen extract 334 prevalence [Abstact] 333, [Abstract] Crawford LV 533 492 de Gara PF 64 prevalence in Colombia 525 D Marks MB 66 prevention 233 Influenza vaccine, testing [Abstract] 69 provoked by drugs 453 Dapsone [Abstract] 188 Inhaler, metered dose 169 seasonal 315 Dermatitis Interleukin 2, 47 treatment [Abstract] 34, atopic 233 Interleukin 4, 354 [Abstract] 52, 169, 175, 245, 267, [Ab- contact 203, [Abstract] 330 Ipratropium bromide [Abstract] 52, 524 stract] 524, 488, 500 effects of irritants [Abstract] 330 treatment during pregnancy 123 Dermatomyositis [Abstract] 339, [Abstract] treatment in infants [Abstract] 506 353 K Asthma, bronchial Devices, inhalation 255 hyperresponsiveness 261 Diabetes mellitus 5 Kawasaki disease 18 Asthma, CD4 and CD8 on antigen-activated Diltiazem 175 Ketotifen 233, 245 VOLUME 68, JUNE, 1992 Pemirolast 488 L T Pentamidine [Abstract] 188 Labeling, misleading 200 Pentapeptide [Letter] 68 Terbutaline [Abstract] 34 Latex 203 Pirbuterol 23 Terfenadine 190 allergy 453 Platelet activator factor 190 Testing fixation [Abstract] 370 Polymositis [Abstract] 353 allergosorbent 293 Lavage, bronchodilator 159 Pregnancy, asthma during 123 basophil histamine release 293 Lobster, allergy to 360 Priming, metered inhaler 169 challenge, oral 293 Lupus erythematosus systemic [Abstract] Procaterol 267 challenge, inhalation 293 514 Provocation, nasal 274 EAST 293 Lymphadenitis 149 FAST 293 Lymphadenopathy 149 MAST 293 Lymphangioleiomyomatosis, pulmonary 307 radioallergosorbent 293 R skin 93 Radioallergosorbent test 3, 35 delayed hypersensitivity 149 M Reactions nasal provocation 331 anaphylactoid 453 Theophylline, sustained release 500 Mediator release 159 late phase 190, [Abstract] 481 Thromboxane A, synthetase inhibitor 53 Meiabisulfite 453 Reactivity, bronchial [Abstract] 52 Toxic epidermal, necrolysis, due to vanco- Metered-dose inhaler 25 Receiver operator characteristic 3 mycin 345 Metered-dose inhalers, infants [Abstract] 196 Resistance, total respiratory 155 Triamcinolone 228 Milk, cow, allergy to 200 Respiratory failure [Abstract] 344 Trimethoprim-dapsone [Abstract] 188 Mite, house dust 159 Rh hemolytic disease of the newborn [Ab- Turbuhaler 255 Mucociliary transport 53 stract] 179 Myasthenia gravis [Abstract] A-22, 467 Rh(D) immune globulin [Abstract] 179 Mycobacteria, atypical 149 Rheumatoid factor [Abstract] 370 Rhinitis U allergic 273 N immunotherapy 334 Urticaria, cold 27 treatment 30, 190, 228, 348 exercise-induced 58 Nebuhaler 255 Rhinitis, exercise-induced 58 treatment 190 Nedocromil sodium 143 Rhinitis, perennial, diagnosis 331 Nifedipine 175 Risk, HIV 197 Rubber 203 Vv O Vancomycin, toxic epidermal necrolysis 345 S Oscillation, forced 155 Ventilation, mechanical, face mask [Ab- Otitis media, acute [Abstract] 318 Scleroderma, localized [Abstract] 514 stract] 344 Sensitivity 3 Skin testing, allergy 35 P Smoking, passive [Abstract] A-22 Specificity 3 Z PPD-Battey 149 Squid, hypersensitivity to 483 Parinaud’s oculoglandular syndrome 149 Sulfite 453 Zidovudine [Abstract] 188 ANNALS OF ALLERGY ]